Relationship between treatment delay and final infarct size in STEMI patients treated with abciximab and primary PCI
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Relationship between treatment delay and final infarct size in STEMI patients treated with abciximab and primary PCI ; volume:12 ; number:1 ; day:23 ; month:2 ; year:2012 ; pages:1-9 ; date:12.2012
BMC cardiovascular disorders ; 12, Heft 1 (23.2.2012), 1-9, 12.2012
- Creator
-
Tödt, Tim
- Contributor
-
Maret, Eva
Alfredsson, Joakim
Janzon, Magnus
Engvall, Jan
Swahn, Eva
SpringerLink (Online service)
- DOI
-
10.1186/1471-2261-12-9
- URN
-
urn:nbn:de:1111-2016032612880
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tödt, Tim
- Maret, Eva
- Alfredsson, Joakim
- Janzon, Magnus
- Engvall, Jan
- Swahn, Eva
- SpringerLink (Online service)
Other Objects (12)
Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
Relationship between the duration of ischemia and final infarct size in STEMI patients treated with abciximab and primary PCI
Could TnI level on admission predict function and infarct size in STEMI patient treated with pPCI – CMR study
Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
2002 Predictors of infarct size and microvascular obstruction assessed by magnetic resonance imaging in patients with STEMI undergoing primary PCI
Hyperkalemia masked by pseudo-stemi infarct pattern and cardiac arrest
Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study
Post-streptokinase PCI in STEMI patients exceeding the 24-h guidelines
Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
Assessment of stess and rest perfusion in patients early after first anterior STEMI patients treated successfully with pPCI
Impaired myocardial perfusion on CMR is associated with increased numbers of classical monocytes in STEMI patients treated by primary PCI
Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
Relationship between the duration of ischemia and final infarct size in STEMI patients treated with abciximab and primary PCI
Could TnI level on admission predict function and infarct size in STEMI patient treated with pPCI – CMR study
Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
2002 Predictors of infarct size and microvascular obstruction assessed by magnetic resonance imaging in patients with STEMI undergoing primary PCI
Hyperkalemia masked by pseudo-stemi infarct pattern and cardiac arrest
Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study
Post-streptokinase PCI in STEMI patients exceeding the 24-h guidelines
Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
Assessment of stess and rest perfusion in patients early after first anterior STEMI patients treated successfully with pPCI
Impaired myocardial perfusion on CMR is associated with increased numbers of classical monocytes in STEMI patients treated by primary PCI
Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
Relationship between the duration of ischemia and final infarct size in STEMI patients treated with abciximab and primary PCI
Could TnI level on admission predict function and infarct size in STEMI patient treated with pPCI – CMR study
Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
2002 Predictors of infarct size and microvascular obstruction assessed by magnetic resonance imaging in patients with STEMI undergoing primary PCI
Hyperkalemia masked by pseudo-stemi infarct pattern and cardiac arrest
Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study
Post-streptokinase PCI in STEMI patients exceeding the 24-h guidelines
Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
Assessment of stess and rest perfusion in patients early after first anterior STEMI patients treated successfully with pPCI